Dr. Wabnitz has extensive experience in clinical development with a unique combination of clinical medicine, pharmacology, toxicology and industry drug development experience. He is Consultant Physician at Royal Adelaide Hospital (FRACP), Australia. He has acted as an investigator and Medical Monitor in over 50 first in human Phase I/II clinical trials as well as previously being the Executive Medical Director of a leading Australian Phase I clinical unit. He is qualified in regulatory submissions, HREC reviews/approvals, clinical trial design and execution, medical monitoring and extensive clinical trial networks within Australia, Asia, EU and the USA.
